Terns Corp (TERN) - Wutah bathi resik saben siji saham kanggo taun lumaku

TERN (Terns Pharmaceuticals) - tandha merek perusahaan

The annual evolution of earnings per share, based on GURU.Markets data, indicates that the -20.60 level serves as a critical benchmark. This trend reflects the battle for market share in obesity treatments driven by molecular safety. Current cash flow relies on grants while awaiting the commercialization of the portfolio. The scientific prestige of Terns Pharmaceuticals (TERN) is based on the development of effective oral liver therapies.

Wutah bathi saben saham ing taun lumaku: Terns Pharma (TERN) kanggo 04.07.2022 - 16.05.2026

Rincian analitis lan laporan data perusahaan Terns Pharmaceuticals (TERN)

- rega saham lan prakiraan rega para ahli:
Rega Terns Pharma|TERN - Target konsensus
- indikator kapitalisasi pasar:
Nilai pasar Terns Corp|TERN - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Aset Bersih saben Saham Terns Pharmaceuticals|TERN - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku ternspharma.com|TERN - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Rasio Utang marang Ekuitas Terns Pharmaceuticals|TERN - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal ternspharma.com|TERN - Gunggung utang perusahaan|Rasio utang marang aset resik Terns Corp|TERN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Terns Pharmaceuticals|Rasio jangkoan perantara ternspharma.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
TERN - Bathi resik|Proyeksi bathi mangsa ngarep Terns Pharmaceuticals|TERN - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Terns Corp|TERN - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Terns Corp|TERN - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Terns Pharmaceuticals|TERN - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ternspharma.com|TERN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Terns Pharmaceuticals
- data pendapatan lan penerimaan dodolan:
TERN - Dodolan perusahaan|Prakiraan volume dodolan Terns Pharma|TERN - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake Terns Corp
Ringkesan analisis perusahaan:Terns Pharma (TERN)
Produk merek Terns Pharmaceuticals, Inc.

Professional selection of sustainable assets is based on an analysis of net profit per share dynamics. By evaluating the annual growth rate of earnings per share, an investor observes the percentage change in EPS compared to the previous period, which for Terns Pharmaceuticals (TERN) reflects progress in the development of gastrointestinal drugs and access to venture capital rather than market cyclicality.

Pesaing utama

PHAT: Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi resik saben saham ing taun iki IRWD|CURX (Curanex) - Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi ing taun lumaku IMRN|EVOK - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Entero Therapeutics ENTO|Tambahing bathi saben saham ing taun lumaku RDHL|PALI - Wutah bathi saben saham ing taun lumaku|JAGX (Jaguar Health Corp) - Wutah bathi saben saham ing taun iki|Biora Therapeutics (BIOR) - Wutah bathi saben saham ing taun lumaku|MORF - Prakiraan wutah bathi resik saben saham ing taun iki